Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$992,719
-$385,080 QoQ
Shares Held
3,945
-37.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#2,549
of 4,153 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Elevated Capital Advisors, LLC holds $4,373,518 across 13 Drug Manufacturers - General names. ABBV ranks #2 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,263 | $1,082,674 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
3,945 | $992,719 | |
| 3 | AMGN |
Amgen Inc
|
1,865 | $675,353 | |
| 4 | PFE |
Pfizer Inc
|
21,185 | $510,134 | |
| 5 | LLY |
ELI LILLY & Co
|
382 | $458,182 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,669 | $326,647 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,351 | $302,103 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
97 | $12,254 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $992,719 | 3,945 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,377,799 | 6,335 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,164,714 | 9,474 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $3,023,217 | 13,057 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,302,987 | 12,407 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $2,599,514 | 12,407 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $2,325,915 | 13,089 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,312,885 | 11,712 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,666,659 | 9,717 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,406,180 | 18,705 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,848,503 | 18,381 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $2,700,221 | 18,115 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $2,288,254 | 16,984 | Shares | Sole | 2023-08-18 | |
| 2023-03-31 | $2,586,415 | 16,229 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $2,616,950 | 16,193 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $1,768,082 | 13,174 | Shares | Sole | 2022-10-06 | |
| 2022-03-31 | $2,125,099 | 13,109 | Shares | Sole | 2022-04-20 | |
| 2021-09-30 | $1,357,867 | 12,588 | Shares | Sole | 2021-10-07 | |
| 2021-03-31 | $1,262,927 | 11,670 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $849,913 | 7,932 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $759,054 | 8,666 | Shares | Sole | 2020-11-27 | |
| 2020-06-30 | $853,773 | 8,696 | Shares | Sole | 2020-09-11 | |
| No filing history on record for this holder in this stock. | ||||||